An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The top five global manufacturers of vaccine adjuvants are GSK, CSL Limited, Brenntag Biosector, Seppic and SPI Pharma, with a combined market share of about 70 per cent. Europe is the largest consumption place, with a consumption market share nearly 43% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 30%.
Market Analysis and Insights: Global Vaccine Adjuvants Market
In 2020, the global Vaccine Adjuvants market size was US$ 762 million and it is expected to reach US$ 1503.9 million by the end of 2027, with a CAGR of 10.2% during 2021-2027.
Global Vaccine Adjuvants Scope and Market Size
Vaccine Adjuvants market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Vaccine Adjuvants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.
Segment by Type, the Vaccine Adjuvants market is segmented into
- Oral
- Subcutaneous
- Intramuscular
- Others
Segment by Application, the Vaccine Adjuvants market is segmented into
- Human Vaccine Adjuvants
- Veterinary Vaccine Adjuvants
Regional and Country-level Analysis:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Competitive Landscape and Vaccine Adjuvants Market Share Analysis
Vaccine Adjuvants market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Vaccine Adjuvants product introduction, recent developments, Vaccine Adjuvants sales by region, type, application and by sales channel.
The major companies include:
- SEPPIC
- SDA BIO
- Brenntag Biosector
- SPI Pharma
- MVP Laboratories
- Tj Kaiwei
- Novavax
- Zhuoyue
- Aphios
Table of content
1 Study Coverage
1.1 Vaccine Adjuvants Product Introduction
1.2 Market by Type
1.2.1 Global Vaccine Adjuvants Market Size Growth Rate by Type
1.2.2 Oral
1.2.3 Subcutaneous
1.2.4 Intramuscular
1.2.5 Others
1.3 Market by Application
1.3.1 Global Vaccine Adjuvants Market Size Growth Rate by Application
1.3.2 Human Vaccine Adjuvants
1.3.3 Veterinary Vaccine Adjuvants
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vaccine Adjuvants Market Size Estimates and Forecasts
2.1.1 Global Vaccine Adjuvants Revenue 2016-2027
2.1.2 Global Vaccine Adjuvants Sales 2016-2027
2.2 Vaccine Adjuvants Market Size by Region: 2021 Versus 2027
2.3 Vaccine Adjuvants Sales by Region (2016-2027)
2.3.1 Global Vaccine Adjuvants Sales by Region: 2016-2021
2.3.2 Global Vaccine Adjuvants Sales Forecast by Region (2022-2027)
2.3.3 Global Vaccine Adjuvants Sales Market Share by Region (2016-2027)
2.4 Vaccine Adjuvants Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Vaccine Adjuvants Revenue by Region: 2016-2021
2.4.2 Global Vaccine Adjuvants Revenue Forecast by Region (2022-2027)
2.4.3 Global Vaccine Adjuvants Revenue Market Share by Region (2016-2027)
3 Global Vaccine Adjuvants by Manufacturers
3.1 Global Top Vaccine Adjuvants Manufacturers by Sales
3.1.1 Globa
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
